Sublimity’s chief technology officer Ivan Coulter

Irish-founded pharma company Sublimity Therapeutics is considering a potential flotation as it looks to get its flagship solution to market within the(...)

The US Food and Drug Administration approved AbbVie’s treatment for Parkinson’s disease, three months ahead of the scheduled review date.The treatment(...)